tiprankstipranks

Andrew Cittadine Insider Profile

4 Followers
Andrew Cittadine, COO at Monopar Therapeutics Inc, holds 57.62K shares in Monopar Therapeutics Inc (Ticker: MNPR).
tipranks
Andrew Cittadine

Andrew Cittadine
Monopar Therapeutics Inc (MNPR)
COO

Not Ranked
Andrew Cittadine has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$42K
100.00%
A breakdown of Andrew Cittadine's holdings

Insider Roles

Monopar Therapeutics Inc
(MNPR)
COO
Roles that Andrew Cittadine holds in companies

Most Profitable Insider Trade

Stock:
Monopar Therapeutics Inc
(MNPR)
Rating:Informative Buy
Date:Nov 16, 2022 - Nov 16, 2023
Return:-87.80%
The most profitable trade made by Andrew Cittadine

Andrew Cittadine's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Monopar Therapeutics Inc
Apr 02, 2024
COO
Uninformative Buy
2.11K
$41.89K
Success Rate for
MNPR
0 out of 1 profitable transactions on
MNPR
0%
Average Return for
MNPR
Average return per transaction on
MNPR
-87.80%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 01, 2022
Uninformative Buy
$6.44K
-
$0.00
Oct 03, 2022
Uninformative Buy
$1.81K
-
$0.00
Nov 16, 2022
Informative Buy
$49.66K
-
$3.09
-87.80%
Jan 03, 2023
Uninformative Buy
$3.33K
-
$0.00
Apr 04, 2023
Uninformative Buy
$1.60K
-
$0.00
List of latest transactions for each holding click on a transaction to see Andrew Cittadine's performance on stock

Andrew Cittadine insider profile FAQ

What is the percentage of profitable transactions made by Andrew Cittadine?
The percentage of profitable transactions made by Andrew Cittadine is ―.
    What is the average return per transaction made by Andrew Cittadine?
    The average return per transaction made by Andrew Cittadine is ―.
      What stocks does Andrew Cittadine hold?
      Andrew Cittadine holds: MNPR stocks.
        What was Andrew Cittadine’s latest transaction?
        Andrew Cittadine latest transaction was an Uninformative Buy of $2.11K.
          What was Andrew Cittadine's most profitable transaction?
          Andrew Cittadine’s most profitable transaction was an Informative Buy of MNPR stock on November 16, 2022. The return on the trade was -87.80%.
            What is Andrew Cittadine's role in Monopar Therapeutics Inc?
            Andrew Cittadine's role in Monopar Therapeutics Inc is COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.